SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001567619-22-008800
Filing Date
2022-04-21
Accepted
2022-04-21 16:19:57
Documents
1
Period of Report
2021-03-23

Document Format Files

Seq Description Document Type Size
1 FORM 4/A doc1.html 4/A  
1 FORM 4/A doc1.xml 4/A 4360
  Complete submission text file 0001567619-22-008800.txt   6013
Mailing Address 228 PARK AVENUE S. #66643 NEW YORK NY 10003
Business Address 228 PARK AVENUE S. #66643 NEW YORK NY 10003 (516) 962-3186
Cambrian BioPharma Inc (Reporting) CIK: 0001797409 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4/A | Act: 34 | File No.: 001-39980 | Film No.: 22841673

Mailing Address 620 PROFESSIONAL DRIVE GAITHERSBURG MD 20879
Business Address 620 PROFESSIONAL DRIVE GAITHERSBURG MD 20879 (240) 243-8000
Sensei Biotherapeutics, Inc. (Issuer) CIK: 0001829802 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations